<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: Vascular malformation is associated with <z:hpo ids='HP_0003256'>coagulopathies</z:hpo>, especially when hemostasis is challenged </plain></SENT>
<SENT sid="1" pm="."><plain>CASE PRESENTATION: We present the case of an 11-year-old Hispanic girl with <z:e sem="disease" ids="C0022739" disease_type="Disease or Syndrome" abbrv="KTS">Klippel-Trenaunay-Weber syndrome</z:e> that developed <z:hpo ids='HP_0005521'>disseminated intravascular coagulation</z:hpo> after minor surgery, which was controlled by blood product transfusions and enoxaparin to address an ongoing consumptive <z:hpo ids='HP_0003256'>coagulopathy</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The patient, however, developed <z:e sem="disease" ids="C0004610" disease_type="Disease or Syndrome" abbrv="">bacteremia</z:e> and liver trauma that resulted in severe <z:mp ids='MP_0001914'>bleeding</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>To the best of our knowledge, we report here the first known instance of administering recombinant coagulation factor VIIa to control <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mp ids='MP_0001914'>bleeding</z:mp> in a patient with <z:e sem="disease" ids="C0022739" disease_type="Disease or Syndrome" abbrv="KTS">Klippel-Trenaunay-Weber syndrome</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSIONS: This case illustrates the concept of enoxaparin maintenance to suppress an ongoing consumptive <z:hpo ids='HP_0003256'>coagulopathy</z:hpo> and the use of recombinant coagulation factor VIIa to control its potentially fatal severe <z:mp ids='MP_0001914'>bleeding</z:mp> episodes </plain></SENT>
</text></document>